Advertisement
Advertisement

ETNB

ETNB logo

89bio Inc

7.99
USD
+0.09
+1.14%
Dec 17, 15:59 UTC -5
Closed
...

89bio Inc Profile

About

89bio Inc. is clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, BIO89-100, is being developed for the treatment of nonalcoholic steatohepatitis. 89bio Inc. is headquartered in San Francisco.

Info & Links

CEO

Rohan Palekar

Headquarters

142 SANSOME STREET, SECOND FLOOR
SAN FRANCISCO, CA 94104, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.89bio.com

Auditor

KPMG LLP

Share holders

5

Employees

70

89bio Inc Statistics

Valuation Measures

Market Capitalization2

847.98M

Enterprise Value

792.11M

Enterprise Value/EBITDA(ttm)

-2.53

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.00

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-59.58%

Return on Invested Capital(ttm)

-61.86%

Return on Assets(ttm)

-52.21%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-312.96M

Net Income Available to Common(ttm)

-288.96M

Diluted EPS(ttm)

-2.91

Share Statistics

Beta (5Y Monthly)

1.12

52-Week Change

-11.71%

S&P 500 52-Week Change

27.63%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

106.13M

Dividend Yield

0.00%

Float4

103.15M

% Held by Insiders

2.80%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

423.77M

Total Cash Per Share(mrq)

3.99

Total Debt(mrq)

35.54M

Total Debt/Equity(mrq)

9.40%

Current Ratio(mrq)

11.66%

Quick Ratio(mrq)

11.66%

Book Value Per Share(mrq)

3.56

Cash Flow

Operating Cash Flow Per Share(ytd)

-2.30

Free Cash Flow(ytd)

-246.24M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement